BCRX
#1851
BioCryst Pharmaceuticals, Inc. - Common Stock
9.8 2 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.51%
Monthly Change
+6.16%
6 month change
+13.53%
Year Change
+17.32%
Previous Close
9.8 7
Open
9.8 2
Low
9.8 2
High
9.8 2
Volume
139
Financials
- Market Capitalization 2.51 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
6.45
Price to sales ratio
1.95
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1826 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 23.08 USD | -3.35% | -5.22% | +17.40% | +2.81% | 2.61 B USD | ||
| 1846 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.61 USD | -2.48% | -0.54% | -1.42% | -16.03% | 2.52 B USD | ||
| 1857 |  PGEN Precigen, Inc. - Common Stock | 6.95 USD | -3.34% | -2.80% | +17.00% | +54.79% | 2.49 B USD | ||
| 1862 |  NKTR Nektar Therapeutics - Common Stock | 72.52 USD | -2.72% | -0.67% | +2.37% | -1.02% | 2.48 B USD |
Frequently asked questions about BioCryst Pharmaceuticals Inc
What is the BioCryst Pharmaceuticals Inc stock price today?
The current price of BioCryst Pharmaceuticals Inc (BCRX) is 9.82. Over the past 24 hours, the stock has changed by -0.51%. Follow the BCRX chart for real-time price dynamics.
What is the stock ticker of BioCryst Pharmaceuticals Inc?
BioCryst Pharmaceuticals Inc trades under the ticker BCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioCryst Pharmaceuticals Inc stock going up?
BCRX has changed by +3.37% over the last week, +6.16% over the last month, and +17.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BioCryst Pharmaceuticals Inc?
BioCryst Pharmaceuticals Inc currently has a market capitalization of 2.51 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were BioCryst Pharmaceuticals Inc earnings last quarter?
Last quarter, BioCryst Pharmaceuticals Inc reported earnings of 0.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was BioCryst Pharmaceuticals Inc revenue for the last quarter?
BioCryst Pharmaceuticals Inc reported quarterly revenue of 218.25 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BioCryst Pharmaceuticals Inc net income for the last quarter?
BioCryst Pharmaceuticals Inc reported net income of 78.39 M for the last quarter. The previous quarter showed -721.81 M, which means net income changed by +110.86%.
How many employees does BioCryst Pharmaceuticals Inc have?
As of the latest available data, BioCryst Pharmaceuticals Inc has 435 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioCryst Pharmaceuticals Inc EBITDA?
BioCryst Pharmaceuticals Inc EBITDA is 99.94 M, and its EBITDA margin is 45.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioCryst Pharmaceuticals Inc stock?
You can buy BioCryst Pharmaceuticals Inc (BCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioCryst Pharmaceuticals Inc stock?
Investing in BioCryst Pharmaceuticals Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCRX chart and related analysis on metatrader.com as part of your research.